Evidence map›Paper›PMID 37088263›Full record

ArticleMucosal immunology2023

A bifurcated role for c-Maf in Th2 and Tfh2 cells during helminth infection.

Katherine Bao, Uryan Isik Can, Mindy M Miller, Ivy K Brown, Mark Dell'Aringa, Hans Dooms, Max A Seibold, James Scott-Browne, Richard Lee Reinhardt

Open access · greenAbstract read
In one paragraph

Article in Mucosal immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Katherine BaoDepartment of Immunology, Duke University Medical Center, Durham, USA.
Uryan Isik CanDepartment of Immunology and Genomic Medicine, National Jewish Health, Denver, USA.
Mindy M MillerDepartment of Immunology and Genomic Medicine, National Jewish Health, Denver, USA.
Ivy K BrownDepartment of Immunology and Genomic Medicine, National Jewish Health, Denver, USA.
Mark Dell'AringaDepartment of Immunology, Duke University Medical Center, Durham, USA; Department of Immunology and Genomic Medicine, National Jewish Health, Denver, USA.
Hans DoomsDepartment of Immunology and Genomic Medicine, National Jewish Health, Denver, USA; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, USA.
Max A SeiboldCenter for Genes, Environment, and Health, National Jewish Health, Denver, USA; Department of Pediatrics, National Jewish Health, Denver, USA; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, USA.
James Scott-BrowneDepartment of Immunology and Genomic Medicine, National Jewish Health, Denver, USA; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, USA.
Richard Lee ReinhardtDepartment of Immunology, Duke University Medical Center, Durham, USA; Department of Immunology and Genomic Medicine, National Jewish Health, Denver, USA; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, USA. Electronic address: ReinhardtL@NJHealth.org.
National Jewish Health · USDuke University · US

Funding

Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
The Origin and Role of Pulmonary ILC2 Subsets in Anti-Helminth ImmunityR01AI156901 · NIAID · NATIONAL JEWISH HEALTH · PI REINHARDT, RICHARD LEE · 2020 to 2024
$2.8M
The Role of BATF in Allergic Inflammation and Anti-Helminth ImmunityR01AI119004 · NIAID · NATIONAL JEWISH HEALTH · PI REINHARDT, RICHARD LEE · 2015 to 2019
$1.8M
NIAID NIH HHS R01 AI119004NIAID NIH HHS R01 AI156901NIAID NIH HHS T32 AI074491
6 · The paper itself

Abstract

Differences in transcriptomes, transcription factor usage, and function have identified T follicular helper 2 (Tfh2) cells and T helper 2 (Th2) cells as distinct clusters of differentiation 4+",(CD4) T-cell subsets in settings of type-2 inflammation. Although the transcriptional programs driving Th2 cell differentiation and cytokine production are well defined, dependence on these classical Th2 programs by Tfh2 cells is less clear. Using cytokine reporter mice in combination with transcription factor inference analysis, the b-Zip transcription factor c-Maf and its targets were identified as an important regulon in both Th2 and Tfh2 cells. Conditional deletion of c-Maf in T cells confirmed its importance in type-2 cytokine expression by Th2 and Tfh2 cells. However, while c-Maf was not required for Th2-driven helminth clearance or lung eosinophilia, it was required for Tfh2-driven Immunoglobulin E production and germinal center formation. This differential regulation of cell-mediated and humoral immunity by c-Maf was a result of redundant pathways in Th2 cells that were absent in Tfh2 cells, and c-Maf-specific mechanisms in Tfh2 cells that were absent in Th2 cells. Thus, despite shared expression by Tfh2 and Th2 cells, c-Maf serves as a unique regulator of Tfh2-driven humoral hallmarks during type-2 immunity.

Indexed as

HelminthiasisTh2 CellsAnimalsCytokinesGene ExpressionGene Expression RegulationMiceTh1 CellsTranscription FactorsCytokinesTranscription Factors

Identifiers

PMID37088263
PMCPMC10290510
OpenAlexW4366754839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.